Background: Irritable Bowel Syndrome (IBS) is a heterogeneous gastrointestinal disorder characterized by complex brain-gut interactions. Patient Similarity Networks (PSNs) offer a novel approach for exploring this heterogeneity and identifying clinically relevant patient subgroups. Methods: We analyzed data from 78 participants (49 IBS patients and 29 healthy controls) with 36 brain morphometric measures (FreeSurfer v7.4.1) and 6 measures of cognitive functions (5 RBANS domain indices plus a Total Scale score). PSNs were constructed using multiple similarity measures (Euclidean, cosine, correlation-based) with Gaussian kernel transformation. We performed community detection (Louvain algorithm), centrality analyses, feature importance analysis, and correlations with symptom severity. Statistical validation included bootstrap confidence intervals and permutation testing. Results: The PSN comprised 78 nodes connected by 469 edges, with four communities detected. These communities did not significantly correspond to diagnostic groups (Adjusted Rand Index = 0.011, permutation p=0.212), indicating IBS patients and healthy controls were intermixed. However, each community exhibited distinct neurobiological profiles: Community 1 (oldest, preserved cognition) showed elevated intracranial volume but reduced subcortical gray matter; Community 2 (youngest, most severe IBS symptoms) had elevated cortical volumes but reduced white matter; Community 3 (most balanced IBS/HC ratio, mildest IBS symptoms) showed the largest subcortical volumes; Community 4 (lowest cognitive performance across multiple domains) displayed the lowest RBANS scores alongside high IBS prevalence. Top network features included subcortical structures, corpus callosum, and cognitive indices (Language, Attention). Conclusions: PSN identifies brain-cognition communities that cut across diagnostic categories, with distinct feature profiles suggesting different hypothesis-generating neurobiological patterns within IBS that may inform personalized treatment strategies.
{"title":"Patient Similarity Networks for Irritable Bowel Syndrome: Revisiting Brain Morphometry and Cognitive Features.","authors":"Arvid Lundervold, Julie Billing, Birgitte Berentsen, Astri J Lundervold","doi":"10.3390/diagnostics16020357","DOIUrl":"10.3390/diagnostics16020357","url":null,"abstract":"<p><p><b>Background:</b> Irritable Bowel Syndrome (IBS) is a heterogeneous gastrointestinal disorder characterized by complex brain-gut interactions. Patient Similarity Networks (PSNs) offer a novel approach for exploring this heterogeneity and identifying clinically relevant patient subgroups. <b>Methods:</b> We analyzed data from 78 participants (49 IBS patients and 29 healthy controls) with 36 brain morphometric measures (FreeSurfer v7.4.1) and 6 measures of cognitive functions (5 RBANS domain indices plus a Total Scale score). PSNs were constructed using multiple similarity measures (Euclidean, cosine, correlation-based) with Gaussian kernel transformation. We performed community detection (Louvain algorithm), centrality analyses, feature importance analysis, and correlations with symptom severity. Statistical validation included bootstrap confidence intervals and permutation testing. <b>Results:</b> The PSN comprised 78 nodes connected by 469 edges, with four communities detected. These communities did not significantly correspond to diagnostic groups (Adjusted Rand Index = 0.011, permutation p=0.212), indicating IBS patients and healthy controls were intermixed. However, each community exhibited distinct neurobiological profiles: Community 1 (oldest, preserved cognition) showed elevated intracranial volume but reduced subcortical gray matter; Community 2 (youngest, most severe IBS symptoms) had elevated cortical volumes but reduced white matter; Community 3 (most balanced IBS/HC ratio, mildest IBS symptoms) showed the largest subcortical volumes; Community 4 (lowest cognitive performance across multiple domains) displayed the lowest RBANS scores alongside high IBS prevalence. Top network features included subcortical structures, corpus callosum, and cognitive indices (Language, Attention). <b>Conclusions:</b> PSN identifies brain-cognition communities that cut across diagnostic categories, with distinct feature profiles suggesting different hypothesis-generating neurobiological patterns within IBS that may inform personalized treatment strategies.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"16 2","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.3390/diagnostics16020343
Jung Won Kwak, Sung Bum Cho, Ki Choon Sim, Jeong Woo Kim, In Young Choi, Yongwon Cho
Background/Objectives: Early detection of hepatocellular carcinoma (HCC), particularly small lesions (<2 cm), which is crucial for curative treatment, remains challenging with conventional liver dynamic computed tomography (LDCT). We aimed to develop a deep learning algorithm to generate synthetic CT during hepatic arteriography (CTHA) from non-invasive LDCT and evaluate its lesion detection performance. Methods: A cycle-consistent generative adversarial network with an attention module [Unsupervised Generative Attentional Networks with Adaptive Layer-Instance Normalization (U-GAT-IT)] was trained using paired LDCT and CTHA images from 277 patients. The model was validated using internal (68 patients, 139 lesions) and external sets from two independent centers (87 patients, 117 lesions). Two radiologists assessed detection performance using a 5-point scale and the detection rate. Results: Synthetic CTHA significantly improved the detection of sub-centimeter (<1 cm) HCCs compared with LDCT in the internal set (69.6% vs. 47.8%, p < 0.05). This improvement was robust in the external set; synthetic CTHA detected a greater number of small lesions than LDCT. Quantitative metrics (structural similarity index measure and peak signal-to-noise ratio) indicated high structural fidelity. Conclusions: Deep-learning-based synthetic CTHA significantly enhanced the detection of small HCCs compared with standard LDCT, offering a non-invasive alternative with high detection sensitivity, which was validated across multicentric data.
{"title":"Improved Detection of Small (<2 cm) Hepatocellular Carcinoma via Deep Learning-Based Synthetic CT Hepatic Arteriography: A Multi-Center External Validation Study.","authors":"Jung Won Kwak, Sung Bum Cho, Ki Choon Sim, Jeong Woo Kim, In Young Choi, Yongwon Cho","doi":"10.3390/diagnostics16020343","DOIUrl":"10.3390/diagnostics16020343","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Early detection of hepatocellular carcinoma (HCC), particularly small lesions (<2 cm), which is crucial for curative treatment, remains challenging with conventional liver dynamic computed tomography (LDCT). We aimed to develop a deep learning algorithm to generate synthetic CT during hepatic arteriography (CTHA) from non-invasive LDCT and evaluate its lesion detection performance. <b>Methods:</b> A cycle-consistent generative adversarial network with an attention module [Unsupervised Generative Attentional Networks with Adaptive Layer-Instance Normalization (U-GAT-IT)] was trained using paired LDCT and CTHA images from 277 patients. The model was validated using internal (68 patients, 139 lesions) and external sets from two independent centers (87 patients, 117 lesions). Two radiologists assessed detection performance using a 5-point scale and the detection rate. <b>Results:</b> Synthetic CTHA significantly improved the detection of sub-centimeter (<1 cm) HCCs compared with LDCT in the internal set (69.6% vs. 47.8%, <i>p</i> < 0.05). This improvement was robust in the external set; synthetic CTHA detected a greater number of small lesions than LDCT. Quantitative metrics (structural similarity index measure and peak signal-to-noise ratio) indicated high structural fidelity. <b>Conclusions:</b> Deep-learning-based synthetic CTHA significantly enhanced the detection of small HCCs compared with standard LDCT, offering a non-invasive alternative with high detection sensitivity, which was validated across multicentric data.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"16 2","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12840521/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.3390/diagnostics16020355
Miriam Rinneburger, Heike Carolus, Andra-Iza Iuga, Mathilda Weisthoff, Simon Lennartz, Nils Große Hokamp, Liliana Lourenco Caldeira, Astha Jaiswal, David Maintz, Fabian Christopher Laqua, Bettina Baeßler, Tobias Klinder, Thorsten Persigehl
Background/Objectives: Accurate assessment of lymph nodes is of paramount importance for correct cN staging in head and neck cancer; however, it is very time-consuming for radiologists, and lymph node metastases of head and neck cancers may show distinct characteristics, such as central necrosis or very large size. Here, we evaluate the performance of a previously developed generic cervical lymph node segmentation model in a cohort of patients with head and neck cancer. Methods: In our retrospective single-center, multi-vendor study, we included 125 patients with head and neck cancer with at least one untreated lymph node metastasis. On the respective cervical CT scan, an experienced radiologist segmented lymph nodes semi-automatically. All 3D segmentations were confirmed by a second reader. These manual segmentations were compared to segmentations generated by an AI model previously trained on a different dataset of varying cancers. Results: In cervical CT scans from 125 patients (61.9 years ± 10.6, 100 men), 3656 lymph nodes were segmented as ground-truth, including 544 clinical metastases. The AI achieved an average recall of 0.70 with 6.5 false positives per CT scan. The average global Dice accounts for 0.73 per scan, with an average Hausdorff distance of 0.88 mm. When analyzing the individual nodes, segmentation accuracy was similar for non-metastatic and metastatic lymph nodes, with a sensitivity of 0.89 and 0.85. Localization performance was lower for metastatic than for non-metastatic lymph nodes, with a recall of 0.65 and 0.74, respectively. Model performance was worse for enlarged nodes (short-axis diameter ≥ 15 mm), with a recall of 0.36 and a sensitivity of 0.67. Conclusions: The AI model for generic cervical lymph node segmentation shows good performance for smaller nodes (SAD ≤ 15 mm) with respect to localization and segmentation accuracy. However, for clearly enlarged and necrotic nodes, a retraining of the generic AI algorithm seems to be required for accurate cN staging.
{"title":"Automated Lymph Node Localization and Segmentation in Patients with Head and Neck Cancer: Opportunities and Limitations of Using a Generic AI Model.","authors":"Miriam Rinneburger, Heike Carolus, Andra-Iza Iuga, Mathilda Weisthoff, Simon Lennartz, Nils Große Hokamp, Liliana Lourenco Caldeira, Astha Jaiswal, David Maintz, Fabian Christopher Laqua, Bettina Baeßler, Tobias Klinder, Thorsten Persigehl","doi":"10.3390/diagnostics16020355","DOIUrl":"10.3390/diagnostics16020355","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Accurate assessment of lymph nodes is of paramount importance for correct cN staging in head and neck cancer; however, it is very time-consuming for radiologists, and lymph node metastases of head and neck cancers may show distinct characteristics, such as central necrosis or very large size. Here, we evaluate the performance of a previously developed generic cervical lymph node segmentation model in a cohort of patients with head and neck cancer. <b>Methods:</b> In our retrospective single-center, multi-vendor study, we included 125 patients with head and neck cancer with at least one untreated lymph node metastasis. On the respective cervical CT scan, an experienced radiologist segmented lymph nodes semi-automatically. All 3D segmentations were confirmed by a second reader. These manual segmentations were compared to segmentations generated by an AI model previously trained on a different dataset of varying cancers. <b>Results:</b> In cervical CT scans from 125 patients (61.9 years ± 10.6, 100 men), 3656 lymph nodes were segmented as ground-truth, including 544 clinical metastases. The AI achieved an average recall of 0.70 with 6.5 false positives per CT scan. The average global Dice accounts for 0.73 per scan, with an average Hausdorff distance of 0.88 mm. When analyzing the individual nodes, segmentation accuracy was similar for non-metastatic and metastatic lymph nodes, with a sensitivity of 0.89 and 0.85. Localization performance was lower for metastatic than for non-metastatic lymph nodes, with a recall of 0.65 and 0.74, respectively. Model performance was worse for enlarged nodes (short-axis diameter ≥ 15 mm), with a recall of 0.36 and a sensitivity of 0.67. <b>Conclusions:</b> The AI model for generic cervical lymph node segmentation shows good performance for smaller nodes (SAD ≤ 15 mm) with respect to localization and segmentation accuracy. However, for clearly enlarged and necrotic nodes, a retraining of the generic AI algorithm seems to be required for accurate cN staging.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"16 2","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12840324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.3390/diagnostics16020345
Jungtaek Park, Sang Hoon Oh, Ae Kyung Gong, Jee Yong Lim, Sun Hee Woo, Won Jung Jeong, Ji Hoon Kim, In Soo Kim, Soo Hyun Kim
Objectives: This study aimed to compare the predictive performance of the Korean Triage and Acuity Scale (KTAS) and the National Early Warning Score (NEWS) for serious adverse events (SAEs), including mortality and intensive care unit (ICU) admission, during emergency department (ED) stay. We also evaluated whether combining the two systems improves prediction accuracy. Methods: This retrospective study included adult patients (≥19 years) who presented to a university-affiliated ED between October and December 2024. KTAS and NEWS were assessed simultaneously at triage. NEWS2 was calculated retrospectively based on routinely documented vital signs and medical history without performing routine arterial blood gas analysis. The primary outcome was the occurrence of SAE during the ED stay. Predictive performance was evaluated using receiver operating characteristic (ROC) curves and the area under the curve (AUC), and logistic regression models were used to identify independent associations. Results: A total of 4216 patients were analyzed, of whom 255 (6.0%) experienced SAEs. All three scores-KTAS, NEWS and NEWS2-were independently associated with the occurrence of SAEs. The AUCs for KTAS, NEWS and NEWS2 were 0.75 (95% CI, 0.74-0.76), 0.73 (95% CI, 0.71-0.74) and 0.73 (95% CI, 0.71-0.74), respectively. Combining KTAS with NEWS or NEWS2 significantly improved predictive accuracy (AUC 0.81, 95% CI 0.79-0.82; p < 0.001). Conclusions: Both KTAS and NEWS/NEWS2 reliably predicted in-ED adverse outcomes, and their combination further enhanced prognostic performance. Integrating physiology-based early warning scores with structured triage systems may help identify high-risk ED patients earlier and optimize resource allocation.
目的:本研究旨在比较韩国分诊和急性程度量表(KTAS)和国家早期预警评分(NEWS)对急诊科(ED)住院期间严重不良事件(SAEs)的预测性能,包括死亡率和重症监护病房(ICU)入住。我们还评估了结合两个系统是否能提高预测精度。方法:这项回顾性研究纳入了2024年10月至12月在大学附属急诊科就诊的成年患者(≥19岁)。KTAS和NEWS在分诊时同时接受评估。NEWS2是在不进行常规动脉血气分析的情况下,根据常规记录的生命体征和病史回顾性计算的。主要观察指标为急诊期间SAE的发生情况。使用受试者工作特征(ROC)曲线和曲线下面积(AUC)来评估预测性能,并使用逻辑回归模型来识别独立关联。结果:共分析4216例患者,其中255例(6.0%)发生了SAEs。ktas、NEWS和news2三项评分均与急性脑损伤的发生独立相关。KTAS、NEWS和NEWS2的auc分别为0.75 (95% CI, 0.74-0.76)、0.73 (95% CI, 0.71-0.74)和0.73 (95% CI, 0.71-0.74)。将KTAS与NEWS或NEWS2结合可显著提高预测准确性(AUC 0.81, 95% CI 0.79-0.82; p < 0.001)。结论:KTAS和NEWS/NEWS2都能可靠地预测ed内不良结局,它们的结合进一步提高了预后表现。将基于生理学的早期预警评分与结构化分诊系统相结合,可能有助于早期识别高危ED患者并优化资源分配。
{"title":"Prognostic Performance of the Korean Triage and Acuity Scale Combined with the National Early Warning Score for Predicting Mortality and ICU Admission at Emergency Department Triage: A Retrospective Observational Study.","authors":"Jungtaek Park, Sang Hoon Oh, Ae Kyung Gong, Jee Yong Lim, Sun Hee Woo, Won Jung Jeong, Ji Hoon Kim, In Soo Kim, Soo Hyun Kim","doi":"10.3390/diagnostics16020345","DOIUrl":"10.3390/diagnostics16020345","url":null,"abstract":"<p><p><b>Objectives</b>: This study aimed to compare the predictive performance of the Korean Triage and Acuity Scale (KTAS) and the National Early Warning Score (NEWS) for serious adverse events (SAEs), including mortality and intensive care unit (ICU) admission, during emergency department (ED) stay. We also evaluated whether combining the two systems improves prediction accuracy. <b>Methods:</b> This retrospective study included adult patients (≥19 years) who presented to a university-affiliated ED between October and December 2024. KTAS and NEWS were assessed simultaneously at triage. NEWS2 was calculated retrospectively based on routinely documented vital signs and medical history without performing routine arterial blood gas analysis. The primary outcome was the occurrence of SAE during the ED stay. Predictive performance was evaluated using receiver operating characteristic (ROC) curves and the area under the curve (AUC), and logistic regression models were used to identify independent associations. <b>Results:</b> A total of 4216 patients were analyzed, of whom 255 (6.0%) experienced SAEs. All three scores-KTAS, NEWS and NEWS2-were independently associated with the occurrence of SAEs. The AUCs for KTAS, NEWS and NEWS2 were 0.75 (95% CI, 0.74-0.76), 0.73 (95% CI, 0.71-0.74) and 0.73 (95% CI, 0.71-0.74), respectively. Combining KTAS with NEWS or NEWS2 significantly improved predictive accuracy (AUC 0.81, 95% CI 0.79-0.82; <i>p</i> < 0.001). <b>Conclusions:</b> Both KTAS and NEWS/NEWS2 reliably predicted in-ED adverse outcomes, and their combination further enhanced prognostic performance. Integrating physiology-based early warning scores with structured triage systems may help identify high-risk ED patients earlier and optimize resource allocation.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"16 2","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.3390/diagnostics16020347
Carol Yen, John W Epling, Michelle Rockwell, Monifa Vaughn-Cooke
Diagnostic errors have been a critical concern in healthcare, leading to substantial financial burdens and serious threats to patient safety. The Improving Diagnosis in Health Care report by the National Academies of Sciences, Engineering, and Medicine (NASEM) defines diagnostic errors, focusing on accuracy, timeliness, and communication, which are influenced by clinical knowledge and the broader healthcare system. This review aims to integrate existing literature on diagnostic error from a systems-based perspective and examine the factors across various domains to present a comprehensive picture of the topic. A narrative literature review was structured upon the Systems Engineering Initiative for Patient Safety (SEIPS) model that focuses on six domains central to the diagnostic process: Diagnostic Team Members, Tasks, Technologies and Tools, Organization, Physical Environment, and External Environment. Studies on contributing factors for diagnostic error in these domains were identified and integrated. The findings reveal that the effectiveness of diagnostics is influenced by complex, interconnected factors spanning all six SEIPS domains. In particular, socio-behavioral factors, such as team communication, cognitive bias, and workload, and environmental pressures, stand out as significant but difficult-to-capture contributors in traditional and commonly used data resources like electronic health records (EHRs), which limits the scope of many studies on diagnostic errors. Factors associated with diagnostic errors are often interconnected across healthcare system stakeholders and organizations. Future research should address both technical and behavioral elements within the diagnostic ecosystem to reduce errors and enhance patient outcomes.
{"title":"Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors.","authors":"Carol Yen, John W Epling, Michelle Rockwell, Monifa Vaughn-Cooke","doi":"10.3390/diagnostics16020347","DOIUrl":"10.3390/diagnostics16020347","url":null,"abstract":"<p><p>Diagnostic errors have been a critical concern in healthcare, leading to substantial financial burdens and serious threats to patient safety. The Improving Diagnosis in Health Care report by the National Academies of Sciences, Engineering, and Medicine (NASEM) defines diagnostic errors, focusing on accuracy, timeliness, and communication, which are influenced by clinical knowledge and the broader healthcare system. This review aims to integrate existing literature on diagnostic error from a systems-based perspective and examine the factors across various domains to present a comprehensive picture of the topic. A narrative literature review was structured upon the Systems Engineering Initiative for Patient Safety (SEIPS) model that focuses on six domains central to the diagnostic process: Diagnostic Team Members, Tasks, Technologies and Tools, Organization, Physical Environment, and External Environment. Studies on contributing factors for diagnostic error in these domains were identified and integrated. The findings reveal that the effectiveness of diagnostics is influenced by complex, interconnected factors spanning all six SEIPS domains. In particular, socio-behavioral factors, such as team communication, cognitive bias, and workload, and environmental pressures, stand out as significant but difficult-to-capture contributors in traditional and commonly used data resources like electronic health records (EHRs), which limits the scope of many studies on diagnostic errors. Factors associated with diagnostic errors are often interconnected across healthcare system stakeholders and organizations. Future research should address both technical and behavioral elements within the diagnostic ecosystem to reduce errors and enhance patient outcomes.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"16 2","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12840061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.3390/diagnostics16020348
Margarita Gorodezky, Linda Reichardt, Tom Geisler, Marc-André Weber, Felix G Meinel, Ann-Christin Klemenz
Background/Objectives: Interest in myocardial mapping for cardiac MRI has increased, enabling differentiation of various cardiac diseases through T1, T2, and T2* mapping. This study evaluates the impact of deep learning (DL)-based image reconstruction on the mean and standard deviation (SD) of these techniques. Methods: Fifty healthy adults underwent cardiac MRI, with images reconstructed using the AIR Recon DL prototype. This DL approach, which reduces noise and enhances image quality, was applied at three levels and compared to non-DL reconstructions. Results: Analysis focused on the septum to minimize artifacts. For T1 mapping, mean values were 988 ± 50, 981 ± 45, 982 ± 43, and 980 ± 24 ms; for T2 mapping, mean values were 53 ± 5, 54 ± 5, 54 ± 5, and 54 ± 5 ms and for T2* mapping, mean values were 37 ± 5, 37 ± 5, 37 ± 5, and 38 ± 5 ms for no DL and increasing DL levels, respectively. Results showed no significant differences in mean values for any mappings between non-DL and DL reconstructions. However, DL significantly reduced the SD within regions of interest for T1 mapping, enhancing image sharpness and registration accuracy. No significant SD reduction was observed for T2 and T2* mappings. Conclusions: These findings suggest that DL-based reconstructions improve the precision of T1 mapping without affecting mean values, supporting their clinical integration for more accurate cardiac disease diagnosis. Future studies should include patient cohorts and optimized protocols to further validate these findings.
{"title":"Impact of Deep Learning-Based Reconstruction on the Accuracy and Precision of Cardiac Tissue Characterization.","authors":"Margarita Gorodezky, Linda Reichardt, Tom Geisler, Marc-André Weber, Felix G Meinel, Ann-Christin Klemenz","doi":"10.3390/diagnostics16020348","DOIUrl":"10.3390/diagnostics16020348","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Interest in myocardial mapping for cardiac MRI has increased, enabling differentiation of various cardiac diseases through T1, T2, and T2* mapping. This study evaluates the impact of deep learning (DL)-based image reconstruction on the mean and standard deviation (SD) of these techniques. <b>Methods:</b> Fifty healthy adults underwent cardiac MRI, with images reconstructed using the AIR Recon DL prototype. This DL approach, which reduces noise and enhances image quality, was applied at three levels and compared to non-DL reconstructions. <b>Results:</b> Analysis focused on the septum to minimize artifacts. For T1 mapping, mean values were 988 ± 50, 981 ± 45, 982 ± 43, and 980 ± 24 ms; for T2 mapping, mean values were 53 ± 5, 54 ± 5, 54 ± 5, and 54 ± 5 ms and for T2* mapping, mean values were 37 ± 5, 37 ± 5, 37 ± 5, and 38 ± 5 ms for no DL and increasing DL levels, respectively. Results showed no significant differences in mean values for any mappings between non-DL and DL reconstructions. However, DL significantly reduced the SD within regions of interest for T1 mapping, enhancing image sharpness and registration accuracy. No significant SD reduction was observed for T2 and T2* mappings. <b>Conclusions:</b> These findings suggest that DL-based reconstructions improve the precision of T1 mapping without affecting mean values, supporting their clinical integration for more accurate cardiac disease diagnosis. Future studies should include patient cohorts and optimized protocols to further validate these findings.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"16 2","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12840211/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.3390/diagnostics16020352
Barbara Frenna, Raffaella Grimaldi, Salvatore Fiandaca, Renisa Basha, Monica Caprio, Giacomo Emanuele Maria Rizzo, Alessio Verdecchia, Enrico Spinas
Objectives: This systematic review aimed to evaluate the effectiveness of currently available methods for the diagnosis and monitoring of skeletal, dental, and soft tissue changes, as well as the adequacy of follow-up protocols, in adolescents and adults treated with miniscrew-assisted rapid palatal expansion (MARPE). Materials and Methods: This systematic review was conducted in accordance with the PRISMA guidelines. A comprehensive electronic literature search was performed across five databases (PubMed, Scopus, Embase, Cochrane, and Web of Science) to identify prospective and retrospective clinical studies evaluating dental, periodontal, and alveolar bone outcomes associated with MARPE in late adolescent and adult patients. Study selection, data extraction, and risk of bias assessment were independently performed by two reviewers. Risk of bias was assessed using the ROBINS-I tool for non-randomized studies and the RoB 2 tool for randomized studies. The certainty of the evidence was evaluated using the GRADE approach. Owing to substantial methodological heterogeneity and limited follow-up duration, a structured qualitative (narrative) synthesis of the results was performed. Results: A total of 20 studies were included in the systematic review. The reported adverse events primarily involved hard and soft tissues and were identified using cone-beam computed tomography (CBCT), clinical and periodontal examination, panoramic and cephalometric radiography, and digital dental casts. Dental effects, including dental tipping, were frequently reported across the included studies. Alveolar bone loss was reported in 11 studies, buccal alveolar bone dehiscence in 3 studies, and failure of palatal suture opening in 6 studies. In most of the included studies, follow-up was either not reported or limited. Conclusions: The MARPE technique appears to be potentially effective in achieving transverse maxillary expansion in late adolescent and adult patients. However, the included studies report possible adverse events affecting periodontal and alveolar bone tissues, such as alveolar bone thinning and gingival hypertrophy, the assessment of which requires an integrated diagnostic approach combining CBCT imaging with clinical and periodontal examination. Overall, the certainty of the available evidence was low to very low, mainly due to a high risk of bias, methodological heterogeneity, and limited or absent follow-up in most studies. Therefore, the results should be interpreted with caution. Well-designed prospective controlled studies with standardized protocols and long-term follow-up are needed to conclusively evaluate the safety and long-term clinical stability of the MARPE technique.
目的:本系统综述旨在评估目前可用的诊断和监测骨骼、牙齿和软组织变化的方法的有效性,以及随访方案的充分性,在青少年和成人中接受微型辅助快速腭扩张(MARPE)治疗。材料和方法:本系统综述按照PRISMA指南进行。对5个数据库(PubMed、Scopus、Embase、Cochrane和Web of Science)进行了全面的电子文献检索,以确定评估晚期青少年和成年患者与MARPE相关的牙齿、牙周和牙槽骨结局的前瞻性和回顾性临床研究。研究选择、数据提取和偏倚风险评估由两位审稿人独立完成。对非随机研究使用ROBINS-I工具,对随机研究使用rob2工具评估偏倚风险。使用GRADE方法评估证据的确定性。由于方法的异质性和随访时间有限,对结果进行了结构化的定性(叙述性)综合。结果:系统评价共纳入20项研究。报告的不良事件主要涉及硬组织和软组织,并通过锥形束计算机断层扫描(CBCT),临床和牙周检查,全景和头侧x线摄影以及数字牙科模型进行识别。在纳入的研究中,经常报告牙科影响,包括牙科小费。11项研究报告了牙槽骨丢失,3项研究报告了颊牙槽骨裂开,6项研究报告了腭缝线打开失败。在大多数纳入的研究中,随访要么没有报道,要么受到限制。结论:MARPE技术似乎是实现上颌横向扩张的青少年晚期和成人患者潜在有效。然而,纳入的研究报告了可能影响牙周和牙槽骨组织的不良事件,如牙槽骨变薄和牙龈肥大,评估这些不良事件需要将CBCT成像与临床和牙周检查相结合的综合诊断方法。总的来说,现有证据的确定性从低到非常低,主要是由于大多数研究中存在高偏倚风险、方法异质性以及随访有限或缺乏随访。因此,研究结果应谨慎解读。需要精心设计的前瞻性对照研究,标准化方案和长期随访,以最终评估MARPE技术的安全性和长期临床稳定性。
{"title":"Diagnostic Assessment of Periodontal and Dentoalveolar Complications Following Mini-Screw-Assisted Rapid Palatal Expansion in Adults and Late Adolescents: A Systematic Review.","authors":"Barbara Frenna, Raffaella Grimaldi, Salvatore Fiandaca, Renisa Basha, Monica Caprio, Giacomo Emanuele Maria Rizzo, Alessio Verdecchia, Enrico Spinas","doi":"10.3390/diagnostics16020352","DOIUrl":"10.3390/diagnostics16020352","url":null,"abstract":"<p><p><b>Objectives</b>: This systematic review aimed to evaluate the effectiveness of currently available methods for the diagnosis and monitoring of skeletal, dental, and soft tissue changes, as well as the adequacy of follow-up protocols, in adolescents and adults treated with miniscrew-assisted rapid palatal expansion (MARPE). <b>Materials and Methods</b>: This systematic review was conducted in accordance with the PRISMA guidelines. A comprehensive electronic literature search was performed across five databases (PubMed, Scopus, Embase, Cochrane, and Web of Science) to identify prospective and retrospective clinical studies evaluating dental, periodontal, and alveolar bone outcomes associated with MARPE in late adolescent and adult patients. Study selection, data extraction, and risk of bias assessment were independently performed by two reviewers. Risk of bias was assessed using the ROBINS-I tool for non-randomized studies and the RoB 2 tool for randomized studies. The certainty of the evidence was evaluated using the GRADE approach. Owing to substantial methodological heterogeneity and limited follow-up duration, a structured qualitative (narrative) synthesis of the results was performed. <b>Results</b>: A total of 20 studies were included in the systematic review. The reported adverse events primarily involved hard and soft tissues and were identified using cone-beam computed tomography (CBCT), clinical and periodontal examination, panoramic and cephalometric radiography, and digital dental casts. Dental effects, including dental tipping, were frequently reported across the included studies. Alveolar bone loss was reported in 11 studies, buccal alveolar bone dehiscence in 3 studies, and failure of palatal suture opening in 6 studies. In most of the included studies, follow-up was either not reported or limited. <b>Conclusions</b>: The MARPE technique appears to be potentially effective in achieving transverse maxillary expansion in late adolescent and adult patients. However, the included studies report possible adverse events affecting periodontal and alveolar bone tissues, such as alveolar bone thinning and gingival hypertrophy, the assessment of which requires an integrated diagnostic approach combining CBCT imaging with clinical and periodontal examination. Overall, the certainty of the available evidence was low to very low, mainly due to a high risk of bias, methodological heterogeneity, and limited or absent follow-up in most studies. Therefore, the results should be interpreted with caution. Well-designed prospective controlled studies with standardized protocols and long-term follow-up are needed to conclusively evaluate the safety and long-term clinical stability of the MARPE technique.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"16 2","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12840436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background/Objectives: Ultrasonography (US) is a non-invasive and repeatable examination for evaluating chronic constipation. However, few studies have explored treatment decisions based on rectal US findings. To date, the efficacy and safety of elobixibat have not been evaluated using rectal US classification in patients with chronic constipation. This study aimed to evaluate the short-term efficacy and safety of elobixibat in patients with chronic constipation classified as "no fecal retention" by rectal US. Methods: We retrospectively analyzed 32 patients with chronic constipation who underwent rectal US and received elobixibat (10 mg/day) between May 2019 and December 2024. Rectal US findings classified patients into four groups: no fecal retention, fecal retention without hard stools, fecal retention with hard stools, and gas retention. The primary endpoint was the response rate of spontaneous bowel movements (SBMs) within 3 days after starting elobixibat in the "no fecal retention" group. Results: Among 18 patients in the "no fecal retention" group, 94.4% achieved SBMs within 3 days, indicating a favorable short-term response. Adverse events included abdominal distension and abdominal pain, each observed in one patient (3.1%). Conclusions: Elobixibat was effective and well tolerated in patients with chronic constipation classified by rectal US findings.
{"title":"Short-Term Efficacy and Safety of Elobixibat for Chronic Constipation Assessed by Rectal Ultrasonography: A Retrospective Observational Study.","authors":"Momoko Tsuda, Tomoyuki Onodera, Kanako Konishi, Norishige Maiya, Mio Matsumoto, Kimitoshi Kubo, Sayaka Kudo, Yoshiyuki Hosoi, Mototsugu Kato","doi":"10.3390/diagnostics16020354","DOIUrl":"10.3390/diagnostics16020354","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Ultrasonography (US) is a non-invasive and repeatable examination for evaluating chronic constipation. However, few studies have explored treatment decisions based on rectal US findings. To date, the efficacy and safety of elobixibat have not been evaluated using rectal US classification in patients with chronic constipation. This study aimed to evaluate the short-term efficacy and safety of elobixibat in patients with chronic constipation classified as \"no fecal retention\" by rectal US. <b>Methods:</b> We retrospectively analyzed 32 patients with chronic constipation who underwent rectal US and received elobixibat (10 mg/day) between May 2019 and December 2024. Rectal US findings classified patients into four groups: no fecal retention, fecal retention without hard stools, fecal retention with hard stools, and gas retention. The primary endpoint was the response rate of spontaneous bowel movements (SBMs) within 3 days after starting elobixibat in the \"no fecal retention\" group. <b>Results:</b> Among 18 patients in the \"no fecal retention\" group, 94.4% achieved SBMs within 3 days, indicating a favorable short-term response. Adverse events included abdominal distension and abdominal pain, each observed in one patient (3.1%). <b>Conclusions:</b> Elobixibat was effective and well tolerated in patients with chronic constipation classified by rectal US findings.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"16 2","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Point-of-care ultrasound (POCUS) is an essential component of emergency medicine, enabling rapid bedside assessment across a wide spectrum of acute conditions. Its effectiveness, however, remains constrained by operator dependency, variable image quality, and time-critical decision-making. Recent advances in artificial intelligence (AI) offer opportunities to augment POCUS by supporting image acquisition, interpretation, and quantitative analysis. This narrative review synthesizes current evidence on AI-enhanced POCUS applications in emergency care, encompassing trauma, non-traumatic emergencies, integrated workflows, resource-limited settings, and education and training. Across trauma settings, AI-assisted POCUS has demonstrated promising performance for automated detection of pneumothorax, hemothorax, and free intraperitoneal fluid, supporting standardized eFAST examinations and rapid triage. In non-traumatic emergencies, AI-enabled cardiovascular, pulmonary, and abdominal applications provide automated measurements and pattern recognition that can approach expert-level performance when image quality is adequate. Integrated AI-POCUS systems and educational tools further highlight the potential to expand ultrasound access, support non-expert users, and standardize training. Nevertheless, important limitations persist, including limited generalizability, dataset bias, device heterogeneity, and uncertain impact on clinical decision-making and patient outcomes. In conclusion, AI-enhanced POCUS is transitioning from proof-of-concept toward early clinical integration in emergency medicine. While current evidence supports its role as a decision-support tool that may enhance consistency and efficiency, widespread adoption will require prospective multicentre validation, development of representative POCUS-specific datasets, vendor-agnostic solutions, and alignment with clinical, ethical, and regulatory frameworks.
{"title":"AI-Enhanced POCUS in Emergency Care.","authors":"Monica Puticiu, Diana Cimpoesu, Florica Pop, Irina Ciumanghel, Luciana Teodora Rotaru, Bogdan Oprita, Mihai Alexandru Butoi, Vlad Ionut Belghiru, Raluca Mihaela Tat, Adela Golea","doi":"10.3390/diagnostics16020353","DOIUrl":"10.3390/diagnostics16020353","url":null,"abstract":"<p><p>Point-of-care ultrasound (POCUS) is an essential component of emergency medicine, enabling rapid bedside assessment across a wide spectrum of acute conditions. Its effectiveness, however, remains constrained by operator dependency, variable image quality, and time-critical decision-making. Recent advances in artificial intelligence (AI) offer opportunities to augment POCUS by supporting image acquisition, interpretation, and quantitative analysis. This narrative review synthesizes current evidence on AI-enhanced POCUS applications in emergency care, encompassing trauma, non-traumatic emergencies, integrated workflows, resource-limited settings, and education and training. Across trauma settings, AI-assisted POCUS has demonstrated promising performance for automated detection of pneumothorax, hemothorax, and free intraperitoneal fluid, supporting standardized eFAST examinations and rapid triage. In non-traumatic emergencies, AI-enabled cardiovascular, pulmonary, and abdominal applications provide automated measurements and pattern recognition that can approach expert-level performance when image quality is adequate. Integrated AI-POCUS systems and educational tools further highlight the potential to expand ultrasound access, support non-expert users, and standardize training. Nevertheless, important limitations persist, including limited generalizability, dataset bias, device heterogeneity, and uncertain impact on clinical decision-making and patient outcomes. In conclusion, AI-enhanced POCUS is transitioning from proof-of-concept toward early clinical integration in emergency medicine. While current evidence supports its role as a decision-support tool that may enhance consistency and efficiency, widespread adoption will require prospective multicentre validation, development of representative POCUS-specific datasets, vendor-agnostic solutions, and alignment with clinical, ethical, and regulatory frameworks.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"16 2","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839756/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.3390/diagnostics16020339
Kristen Lee, Bhakti Patel, Ruth Samson, Emily Hunt, Christian L Sellers, Takouhie Maldjian
Background/Objectives: This study seeks to evaluate the clinical characteristics of newly diagnosed male breast cancers within the traditionally underserved Bronx population at risk for poorer health outcomes. Methods: We retrospectively searched our database for male patients who presented for mammographic evaluation between 1 January 2016 and 1 October 2024. The primary outcomes were the prevalence of biopsy-proven male breast cancer and its association with gynecomastia and TNM stage at diagnosis. Clinical data, including TNM staging, receptor status, risk factors, and patient demographics, were recorded for patients with biopsy-proven breast cancer based on biopsy results. Two dedicated breast imagers retrospectively evaluated mammograms of these patients to determine by consensus the presence of gynecomastia. Analyses were descriptive in nature. Results: During the study period, 423 screening mammograms and 1775 diagnostic mammograms were performed on male patients. Twenty-six male patients with biopsy-proven breast cancer were identified (two were bilateral and four were multifocal). In total, 69% of our male breast cancer patients (18 out of 26) demonstrated gynecomastia, which was similar across demographic groups, ranging from 63 to 75%. Out of the three patients with Stage 4 disease, two were Black and one was White. Stage 3 or higher disease was seen in 29% of our Black patients, 12% of our White patients, and 0% of our Hispanic patients. Conclusions: Male breast cancer in this Bronx population was frequently associated with gynecomastia and showed notable demographic disparities. Black patients presented with more advanced disease than other demographic groups. These descriptive findings highlight areas of further investigation and may help inform future outreach and early detection efforts in high-risk, underserved communities. This retrospective, single-institution analysis was limited by a small sample size and did not include formal statistical testing; therefore, the findings are descriptive and warrant validation with larger cohorts.
{"title":"Male Breast Cancer in a Bronx Urban Population: A Single-Institution Retrospective Observational Study.","authors":"Kristen Lee, Bhakti Patel, Ruth Samson, Emily Hunt, Christian L Sellers, Takouhie Maldjian","doi":"10.3390/diagnostics16020339","DOIUrl":"10.3390/diagnostics16020339","url":null,"abstract":"<p><p><b>Background/Objectives</b>: This study seeks to evaluate the clinical characteristics of newly diagnosed male breast cancers within the traditionally underserved Bronx population at risk for poorer health outcomes. <b>Methods</b>: We retrospectively searched our database for male patients who presented for mammographic evaluation between 1 January 2016 and 1 October 2024. The primary outcomes were the prevalence of biopsy-proven male breast cancer and its association with gynecomastia and TNM stage at diagnosis. Clinical data, including TNM staging, receptor status, risk factors, and patient demographics, were recorded for patients with biopsy-proven breast cancer based on biopsy results. Two dedicated breast imagers retrospectively evaluated mammograms of these patients to determine by consensus the presence of gynecomastia. Analyses were descriptive in nature. <b>Results</b>: During the study period, 423 screening mammograms and 1775 diagnostic mammograms were performed on male patients. Twenty-six male patients with biopsy-proven breast cancer were identified (two were bilateral and four were multifocal). In total, 69% of our male breast cancer patients (18 out of 26) demonstrated gynecomastia, which was similar across demographic groups, ranging from 63 to 75%. Out of the three patients with Stage 4 disease, two were Black and one was White. Stage 3 or higher disease was seen in 29% of our Black patients, 12% of our White patients, and 0% of our Hispanic patients. <b>Conclusions</b>: Male breast cancer in this Bronx population was frequently associated with gynecomastia and showed notable demographic disparities. Black patients presented with more advanced disease than other demographic groups. These descriptive findings highlight areas of further investigation and may help inform future outreach and early detection efforts in high-risk, underserved communities. This retrospective, single-institution analysis was limited by a small sample size and did not include formal statistical testing; therefore, the findings are descriptive and warrant validation with larger cohorts.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"16 2","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}